We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$693M
AUM Growth
-$53.2M
Cap. Flow
+$17M
Cap. Flow %
2.45%
Top 10 Hldgs %
46.29%
Holding
382
New
110
Increased
31
Reduced
28
Closed
176

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$32.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$18.7M
3
DIS icon
Walt Disney
DIS
+$14.1M
4
TSM icon
TSMC
TSM
+$6.86M
5
AMZN icon
Amazon
AMZN
+$6.38M

Sector Composition

Rank Sector Weight
1 Technology 13.91%
2 Communication Services 5.2%
3 Healthcare 1.02%
4 Materials 0.39%
5 Utilities 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
301
Procter & Gamble
PG
$340B
-1,000
Closed -$126K
PINS icon
302
PUT
Pinterest
PINS
$13.7B
-105,000
Closed -$2.45M
PLAY icon
303
CALL
Dave & Buster's
PLAY
$357M
-8,200
Closed -$254K
PLYA
304
CALL
DELISTED
Playa Hotels & Resorts
PLYA
-20,000
Closed -$116K
RARE icon
305
CALL
Ultragenyx Pharmaceutical
RARE
$2.46B
-6,300
Closed -$261K
RARE icon
306
Ultragenyx Pharmaceutical
RARE
$2.46B
-32,173
Closed -$1.33M
RARE icon
307
PUT
Ultragenyx Pharmaceutical
RARE
$2.46B
-40,000
Closed -$1.66M
RCEL icon
308
CALL
Avita Medical
RCEL
$137M
-10,000
Closed -$52.7K
RCEL icon
309
Avita Medical
RCEL
$137M
-29,650
Closed -$156K
RCEL icon
310
PUT
Avita Medical
RCEL
$137M
-23,500
Closed -$124K
REGN icon
311
CALL
Regeneron Pharmaceuticals
REGN
$72.9B
-4,900
Closed -$3.38M
REMX icon
312
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.91B
-500
Closed -$41.7K
RLMD icon
313
CALL
Relmada Therapeutics
RLMD
$540M
-13,000
Closed -$481K
RLMD icon
314
PUT
Relmada Therapeutics
RLMD
$540M
-27,000
Closed -$1,000K
RUN icon
315
Sunrun
RUN
$2.26B
-2,500
Closed -$69K
SGMO
316
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-34,700
Closed -$170K
SGMO
317
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-32,800
Closed -$161K
SGMO
318
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-50,000
Closed -$245K
SHW icon
319
CALL
Sherwin-Williams
SHW
$84.8B
-1,200
Closed -$246K
SIGA icon
320
CALL
SIGA Technologies
SIGA
$240M
-30,000
Closed -$309K
SIGA icon
321
SIGA Technologies
SIGA
$240M
-18,700
Closed -$193K
SIGA icon
322
PUT
SIGA Technologies
SIGA
$240M
-21,600
Closed -$222K
SITM icon
323
SiTime
SITM
$13.8B
-1,500
Closed -$118K
SITM icon
324
PUT
SiTime
SITM
$13.8B
-5,000
Closed -$394K
SPY icon
325
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
-100,000
Closed -$35.7M

Similar funds

SG3 Management's Q4 2022 Portfolio in Review

As of Q4 2022, SG3 Management held 382 positions worth $693M, down 7.1% from $746M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

SG3 Management's Q4 2022 filing shows 110 new, 31 increased, 28 reduced and 176 closed positions. Its largest new stake was Alphabet (Google) Class A: 232,500 shares worth $20.5M. The largest sale was Tesla, an estimated $32.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 3.7% a quarter earlier, followed by Communication Services and Healthcare.

  • SG3 Management's largest Q4 2022 buy was Alphabet (Google) Class A: 232,500 shares worth $20.5M.
  • SG3 Management added most to Microsoft in Q4 2022, an estimated $85.8M increase.
  • SG3 Management's biggest Q4 2022 reduction was Tesla, cutting an estimated $32.7M.
  • SG3 Management fully exited Alphabet (Google) Class C in Q4 2022, selling an estimated $18.7M.
  • SG3 Management's ten largest holdings make up 46% of its $693M portfolio in Q4 2022.
  • SG3 Management opened 110 new positions and closed 176 in Q4 2022.
  • SG3 Management's portfolio value fell 7.1% quarter-over-quarter to $693M.

Based on SG3 Management's 13F filing for Q4 2022, filed 14 Feb 2023.